Wintertime Is Prime Time for Head Lice: What Parents Need to Know

Head lice can be a wintertime headache for families and schools, but simple precautions can stop the spread of these pesky parasites.

Every year, 6 million to 12 million children in the United States, ages 3 to 11, experience head lice infestations, according to the U.S. Centers for Disease Control and Prevention. Contrary to popular belie...

U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds.

Data on almost 17 million adults nationwide showed the obesity rate -- which has been rising for years -- fell from 46.2% of adults in 2021 to 45.6% in 2023, Harvard University researchers report....

Eat Less Meat, More Beans & Lentils for Protein, New USDA Guidelines Say

Beans, peas and lentils take center stage in newly proposed changes to dietary guidelines for Americans.

In a report released this week by an advisory committee to the Agriculture Department, experts suggest that the protein-packed legumes are the perfect substitute for red or processed meat. They came to that conclusion after analyzing sc...

Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers

An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows.

The drug, imlunestrant, improved progression-free survival in patients whose breast cancer was driven by the female hormone estrogen.

The drug was particularly effective in bre...

Blood Test Might Alert Doctors to Problem Drinking

Have you been boozing more often than usual?

A new blood test might be able to tell if you’re damaging your liver from too many beers, margaritas or belts of scotch, researchers report.

A blood-borne byproduct of alcohol consumption called phosphatidylethanol (PEth) can give doctors a fair idea of how much liver scarring has oc...

'Watch and Wait' May Equal Active Treatment for Early DCIS Breast Cancers, Studies Find

A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer.

According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal carcinoma in situ (DCIS) resulted in breast cancer recurrence rates similar to those of women who h...